- Home
- ARVN vs SPTN Comparison
ARVN vs SPTN Comparison
Compare ARVN & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SPTN
- Stock Information
- Founded
- ARVN 2015
- SPTN 1917
- Country
- ARVN United States
- SPTN United States
- Employees
- ARVN N/A
- SPTN N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SPTN Food Distributors
- Sector
- ARVN Health Care
- SPTN Consumer Discretionary
- Exchange
- ARVN Nasdaq
- SPTN Nasdaq
- Market Cap
- ARVN 614.8M
- SPTN 654.2M
- IPO Year
- ARVN 2018
- SPTN N/A
- Fundamental
- Price
- ARVN $6.13
- SPTN $18.74
- Analyst Decision
- ARVN Buy
- SPTN Hold
- Analyst Count
- ARVN 19
- SPTN 1
- Target Price
- ARVN $21.14
- SPTN $20.00
- AVG Volume (30 Days)
- ARVN 3.3M
- SPTN 251.2K
- Earning Date
- ARVN 05-01-2025
- SPTN 05-29-2025
- Dividend Yield
- ARVN N/A
- SPTN 4.68%
- EPS Growth
- ARVN N/A
- SPTN N/A
- EPS
- ARVN N/A
- SPTN 0.01
- Revenue
- ARVN $426,900,000.00
- SPTN $9,549,324,000.00
- Revenue This Year
- ARVN N/A
- SPTN $5.82
- Revenue Next Year
- ARVN N/A
- SPTN N/A
- P/E Ratio
- ARVN N/A
- SPTN $2,126.14
- Revenue Growth
- ARVN 498.74
- SPTN N/A
- 52 Week Low
- ARVN $5.94
- SPTN $17.30
- 52 Week High
- ARVN $37.38
- SPTN $23.00
- Technical
- Relative Strength Index (RSI)
- ARVN 31.46
- SPTN 37.58
- Support Level
- ARVN $6.51
- SPTN $18.59
- Resistance Level
- ARVN $7.05
- SPTN $19.39
- Average True Range (ATR)
- ARVN 0.58
- SPTN 0.46
- MACD
- ARVN -0.13
- SPTN -0.09
- Stochastic Oscillator
- ARVN 1.37
- SPTN 12.43
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.